Prof.
E.J. Corey
Harvard University (USA)
Prof.
Shinya Yamanaka
Kyoto University (JAPAN) (Informal Consent)
Prof.
Shizuo Akira
Osaka University (JAPAN)
Prof.
Chi-Huey Wong
Academia Sinica, Taiwan and The Scripps Research Institute, USA (TAIWAN)
Prof.
Kyriacos Costa Nicolaou
The Scipps Research Institute and University of California (USA)
Dr.
John C. Lechleiter
CEO, Eli Lilly and Company (USA)
Frontier Methods for Drug Discovery
Prof.
Reuben Jih-Ru Hwu
National Tsing Hua University (TAIWAN)
Prof.
Dave Winkler
CSIRO (AUSTRALIA)
Quantitative Structure-Activity Relationship
Prof.
Ismail Yalcin
Ankara University (TURKEY)
Structure Biology: Protein Structure, Dynamics And Functions
Prof.
Jie-Oh Lee
Korea Advanced Institute of Science and Technology (KOREA)
Computer-Assisted Drug Design
Prof.
Hualiang Jiang
Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CHINA)
Neurological Disease
Prof.
Takeshi Iwatsubo
The University of Tokyo (JAPAN)
Bio-Imaging
Prof.
Yasuteru Urano
The University of Tokyo (JAPAN)
Chemical Biology
Prof.
Motonari Uesugi
Kyoto University (JAPAN)
Drug Delivery/ Drug Targeting
Prof.
Kazunori Kataoka
The University of Tokyo (JAPAN)
Natural Products
Prof.
Daisuke Uemura
Keio University (JAPAN)
Nucleotides / Nucleosides / siRNA Therapeutics
Prof.
Satoshi Obika
Osaka University (JAPAN)
Peptidases
Prof.
Yoshiaki Kiso
Kyoto Pharmaceutical University (JAPAN)
Regulatory Affairs
Prof.
Masahiro Nishijima
National Institute of Health Sciences (JAPAN)
Structure Biology: Protein Structure, Dynamics And Functions
Prof.
Ichio Shimada
The University of Tokyo (JAPAN)
Synthetic And Process Chemistry
Prof.
Yujiro Hayashi
Tokyo University of Science (JAPAN)
Translational Research
Prof.
Ryozo Nagai
The University of Tokyo (JAPAN)
Quantitative Structure-Activity Relationships
Prof.
Hiroshi Chuman
The University of Tokushima (JAPAN)
